INVITRO INVIVO CORRELATION FOR MODIFIED-RELEASE FORMULATIONS

被引：20

作者：

DREWE, J

GUITARD, P

机构：

[1] UNIV HOSP BASEL, KANTONSSPITAL, DEPT RES, CH-4031 BASEL, SWITZERLAND

[2] SANDOZ PHARMA LTD, PHARMA DEV, BASEL, SWITZERLAND

来源：

JOURNAL OF PHARMACEUTICAL SCIENCES | 1993年 / 82卷 / 02期

关键词：

D O I：

10.1002/jps.2600820204

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A correlation of in vitro dissolution rate measurements with in vivo pharmacokinetic results in a human study was obtained for a sustained-release formulation of bromocriptine. Different methods were applied to reach this correlation, and the various outcomes were compared.

引用

页码：132 / 137

页数：6

共 18 条

[11] TREATMENT OF PARKINSONS-DISEASE WITH BROMOCRIPTINE [J].

LIEBERMAN, A ;

KUPERSMITH, M ;

ESTEY, E ;

GOLDSTEIN, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1976, 295 (25) :1400-1404

[12] PHARMACOKINETIC CRITERIA FOR EVALUATION OF RETARD FORMULATIONS [J].

MEIER, J ;

NUESCH, E ;

SCHMIDT, R .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 7 (06) :429-432

[13]

ROSENTHALER J, 1983, DRUG METABOLITE ISOL, P215

[14] BROMOCRIPTINE TREATMENT OF ACROMEGALY [J].

THORNER, MO ;

CHAIT, A ;

AITKEN, M ;

BENKER, G ;

BLOOM, SR ;

MORTIMER, CH ;

SANDERS, P ;

MASON, AS ;

BESSER, GM .

BRITISH MEDICAL JOURNAL, 1975, 1 (5953) :299-303

[15]

VANHATTINGBERG HM, 1984, METHOD FIND EXP CLIN, V6, P589

[16] SUPPRESSION OF PUERPERAL LACTATION WITH AN ERGOT ALKALOID - DOUBLE-BLIND STUDY [J].

VARGA, L ;

WENNER, R ;

LUTTERBECK, PM ;

ERB, H ;

PRYOR, JS .

BMJ-BRITISH MEDICAL JOURNAL, 1972, 2 (5816) :743-+

[17]

VOEGELE D, 1984, METHOD FIND EXP CLIN, V6, P597

[18] APPLICATION OF AKAIKES INFORMATION CRITERION (AIC) IN EVALUATION OF LINEAR PHARMACOKINETIC EQUATIONS [J].

YAMAOKA, K ;

NAKAGAWA, T ;

UNO, T .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1978, 6 (02) :165-175

← 1 2 →